We have joined forces with Momentum Biotechnologies to power drug discovery solutions for the biotech and pharmaceutical industries.

Through this partnership our extensive chemical diversity library is now accessible for high-throughput screening via Momentum’s cutting-edge mass spectrometry-based platforms.

Together, we’re advancing innovation in hit identification and reinforcing the first stages of drug discovery.